Naturopathic approaches to irritable bowel syndrome: protocol for a prospective observational study in academic teaching clinics
Tài liệu tham khảo
Agarwal, 2011, The effect of irritable bowel syndrome on health-related quality of life and health care expenditures, Gastroenterol Clin North Am, 40, 11, 10.1016/j.gtc.2010.12.013
Drossman, 2009, International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit, J Clin Gastroenterol, 43, 541, 10.1097/MCG.0b013e318189a7f9
Ford, 2014, American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation, Am J Gastroenterol, 109, S2, 10.1038/ajg.2014.187
2012
Shen, 2009, Complementary and alternative medicine for treatment of irritable bowel syndrome, Can Fam Phys, 55, 143
World Naturopathic Federation, 2015
World Naturopathic Federation, 2016
Sarris, 2014
Dossett, 2014, Complementary and alternative medicine use by US adults with gastrointestinal conditions: Results from the 2012 National Health Interview Survey, Am J Gastroenterol, 109, 1705, 10.1038/ajg.2014.108
Goldenberg, 2017
Shani-Zur, 2015, Irritable bowel syndrome treatment: a multidisciplinary approach, Harefuah, 154, 52
Wardle, 2012, The intersecting paradigms of naturopathic medicine and public health: opportunities for naturopathic medicine, J Altern Complement Med, 17, 1079, 10.1089/acm.2010.0830
Francis, 1997, The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress, Alim Pharmacol Therapeut, 11, 395, 10.1046/j.1365-2036.1997.142318000.x
Senders, 2014, Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis, Mult Scler, 20, 1102, 10.1177/1352458513517279
Hinchcliff, 2015, Longitudinal evaluation of PROMIS-29 and FACIT-Dyspnea short forms in systemic sclerosis, J Rheumatol, 42, 64, 10.3899/jrheum.140143
Jones, 2017, Validation of patient-reported outcomes measurement information system short forms for use in childhood-onset systemic lupus erythematosus, Arthritis Care Res (Hoboken), 69, 133, 10.1002/acr.22927
Nagaraja, 2014, Construct validity of the patient-reported outcomes measurement information system gastrointestinal symptom scales in systemic sclerosis, Arthritis Care Res, 66, 1725, 10.1002/acr.22337
Mahieu, 2016, Patient-reported outcomes in systemic lupus erythematosus, Rheum Dis Clin North Am, 42, 253, 10.1016/j.rdc.2016.01.001
Schnall, 2017, A health-related quality-of-life measure for use in patients with HIV: a validation study, AIDS Patient Care STDS, 31, 43, 10.1089/apc.2016.0252
Müller-Lissner, 2003, Subject's global assessment of relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials, J Clin Epidemiol, 56, 310, 10.1016/S0895-4356(03)00027-1
The Food Drug Administration, 2010
Camilleri, 2007, Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints, Clin Gastroenterol Hepatol, 5, 534, 10.1016/j.cgh.2007.03.004
Mercer, 2004, The consultation and relational empathy (CARE) measure: development and preliminary validation and reliability of an empathy-based consultation process measure, Fam Pract, 21, 699, 10.1093/fampra/cmh621
Foley, 2017, Patient perceptions of patient-centred care, empathy and empowerment in complementary medicine clinical practice: a cross-sectional study, Adv Integr Med, 4, 22, 10.1016/j.aimed.2017.02.006
Bann, 2010, Provider support in complementary and alternative medicine: exploring the role of patient empowerment, J Altern Complement Med, 16, 745, 10.1089/acm.2009.0381